NOVEL CSF BIOMARKERS FOR ALZHEIMER'S DISEASE AND FRONTOTEMPORAL LOBAR DEGENERATION

摘要

Protein and gene biomarkers that differentially discriminate between various neurodegenerative disorders are utilized in diagnosing a specific neurodegenerative disorder in a subject. Neurodegenerative disorders that can be distinguished from one another include Alzheimer's disease (AD), different forms of Frontotemporal lobar degeneration (FTLD), and different forms of dementia.